Interleukin-4 (IL-4) and interleukin-13 (IL-13) are the characteristic molecules that induce, drive, and prolong the Th-2 answer both in AD and in advanced stages of CTCL [21,22,23,38]. This evidence concerns the gene IL4 and primary cutaneous T-cell non-Hodgkin lymphoma.